search
Back to results

Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour

Primary Purpose

Influenza Vaccine, Behavioral Intervention, Self-benefit

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Self-benefit message
Other-benefit message
Sponsored by
SB Istanbul Education and Research Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Influenza Vaccine

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients hospitalized at medical departments of the hospital who are on the day of discharge

Exclusion Criteria:

  • Egg ellergy
  • Previous allergic reaction to influenza vaccine
  • Pregnancy
  • Cognitive disability

Sites / Locations

  • SB Istanbul Training and Research Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Self-benefit arm

Social-benefit arm

Arm Description

Outcomes

Primary Outcome Measures

Vaccine uptake following the introduction of the pamphlet
Difference in the number of patients in each arm who agree to receive influenza vaccine following the introduction of the pamphlet. The first half of the pamphlet contains information about the the influenza vaccine and the risk groups who are vulnerable to influenza-associated serious diseases. The second half introduces the self-benefit message. And the final part asks if the participant wants to receive the influenza vaccine now.

Secondary Outcome Measures

Vaccine uptake in high and low risk group patients following the introduction of the pamphlet
Vaccine uptake in high and low risk group patients. The first half of the pamphlet contains information about the the influenza vaccine and the risk groups who are vulnerable to influenza-associated serious diseases. The second half introduces the social-benefit message. And the final part asks if the participant wants to receive the influenza vaccine now.

Full Information

First Posted
January 12, 2020
Last Updated
January 13, 2020
Sponsor
SB Istanbul Education and Research Hospital
Collaborators
University of Nottingham
search

1. Study Identification

Unique Protocol Identification Number
NCT04230343
Brief Title
Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour
Official Title
Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza
Study Type
Interventional

2. Study Status

Record Verification Date
January 2020
Overall Recruitment Status
Completed
Study Start Date
November 13, 2016 (Actual)
Primary Completion Date
March 25, 2017 (Actual)
Study Completion Date
March 25, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
SB Istanbul Education and Research Hospital
Collaborators
University of Nottingham

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Influenza vaccine uptake remains low worldwide, inflicting substantial costs to public health and health systems. Messages promoting social welfare have been shown to increase vaccination intentions, and it has been recommended that health professionals communicate the socially beneficial aspects of vaccination. This study aims to provide the first test whether this prosocial vaccination hypothesis applies to the actual vaccination behaviour of high-risk patients by comparing the effects of two motivational messages for promoting vaccination at a tertiary care public hospital in Istanbul, Turkey.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Influenza Vaccine, Behavioral Intervention, Self-benefit, Social-benefit

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigator
Allocation
Randomized
Enrollment
244 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Self-benefit arm
Arm Type
Experimental
Arm Title
Social-benefit arm
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
Self-benefit message
Intervention Description
A pamphlet consisting of a short text and an abstract figure. The top half of the pamphlet described the official criteria for qualifying to be in the risk group. Bottom half indicated that one can gain immunity against influenza by getting the vaccine and included a figure of one smiley face.
Intervention Type
Behavioral
Intervention Name(s)
Other-benefit message
Intervention Description
A pamphlet consisting of a short text and an abstract figure. The top half of the pamphlet described the official criteria for qualifying to be in the risk group. Bottom half indicated that one can gain immunity against influenza by getting the vaccine, and gaining immunity would lower the chances of transmitting the disease to others. The figure included one smiley face surrounded by three other smiley faces.
Primary Outcome Measure Information:
Title
Vaccine uptake following the introduction of the pamphlet
Description
Difference in the number of patients in each arm who agree to receive influenza vaccine following the introduction of the pamphlet. The first half of the pamphlet contains information about the the influenza vaccine and the risk groups who are vulnerable to influenza-associated serious diseases. The second half introduces the self-benefit message. And the final part asks if the participant wants to receive the influenza vaccine now.
Time Frame
On the same day, upto 24 hours
Secondary Outcome Measure Information:
Title
Vaccine uptake in high and low risk group patients following the introduction of the pamphlet
Description
Vaccine uptake in high and low risk group patients. The first half of the pamphlet contains information about the the influenza vaccine and the risk groups who are vulnerable to influenza-associated serious diseases. The second half introduces the social-benefit message. And the final part asks if the participant wants to receive the influenza vaccine now.
Time Frame
On the same day, upto 24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients hospitalized at medical departments of the hospital who are on the day of discharge Exclusion Criteria: Egg ellergy Previous allergic reaction to influenza vaccine Pregnancy Cognitive disability
Facility Information:
Facility Name
SB Istanbul Training and Research Hospital
City
Istanbul
ZIP/Postal Code
34098
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32066407
Citation
Isler O, Isler B, Kopsacheilis O, Ferguson E. Limits of the social-benefit motive among high-risk patients: a field experiment on influenza vaccination behaviour. BMC Public Health. 2020 Feb 17;20(1):240. doi: 10.1186/s12889-020-8246-3.
Results Reference
derived

Learn more about this trial

Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour

We'll reach out to this number within 24 hrs